| 1 |
31897925 | Management of sinonasal adenocarcinomas with anterior skull base extension. | 2020 Dec |
1 |
| 2 |
32731241 | The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. | 2020 |
1 |
| 3 |
19998502 | NT4(Si)-p53(N15)-antennapedia induces cell death in a human hepatocellular carcinoma cell line. | 2009 Dec 14 |
1 |
| 4 |
16528528 | Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. | 2006 Dec |
1 |
| 5 |
15342418 | P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells. | 2004 Sep 1 |
1 |
| 6 |
15611505 | Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma. | 2004 Dec 15 |
1 |
| 7 |
14695155 | Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. | 2003 Dec 15 |
2 |
| 8 |
11802206 | P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection. | 2002 Feb 1 |
1 |
| 9 |
12171874 | Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin. | 2002 Aug |
2 |
| 10 |
11038045 | Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination. | 2000 Aug |
2 |
| 11 |
21541641 | Mutation in the K-ras gene at codon 12 does not correlate with disease progression in colorectal carcinoma patients treated with 5-FU/folinic acid biomodulated chemotherapy. | 1996 Dec |
1 |